XOMA Royalty (XOMA) Amortization - Intangibles (2023 - 2026)
XOMA Royalty (XOMA) reported Amortization - Intangibles of $892000.0 for Q1 2026, up 63.97% on a YoY basis from $544000.0 in Q1 2025, and up 0.9% sequentially from $884000.0 in Q4 2025.
XOMA Royalty (XOMA) Amortization - Intangibles (2023 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 3 years of Amortization - Intangibles data on file, last reported at $892000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization - Intangibles rose 63.97% year-over-year to $892000.0; the trailing twelve-month figure through Mar 2026 stood at $3.0 million (up 144.65% YoY), and the FY2025 full-year result was $3.0 million, up 1337.38% from the prior year.
- Amortization - Intangibles grew to $892000.0 in Q1 2026, from $884000.0 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $892000.0 in Q1 2026 to a low of $224000.0 in Q2 2023.
- A 3-year average of $484000.0 and a median of $384500.0 in 2023 frame the typical range for Amortization - Intangibles.
- Peak annual rise in Amortization - Intangibles reached 63.97% in 2026, while the deepest fall reached 63.97% in 2026.
- Tracing XOMA's Amortization - Intangibles over 3 years: stood at $224000.0 in 2023, then jumped by 294.64% to $884000.0 in 2025, then grew by 0.9% to $892000.0 in 2026.
- Business Quant data shows XOMA's Amortization - Intangibles at $892000.0 in Q1 2026, $884000.0 in Q4 2025, and $655000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 892,000.00 |
| Dec 31, 2025 | 884,000.00 |
| Jun 30, 2025 | 655,000.00 |
| Mar 31, 2025 | 544,000.00 |
| Dec 31, 2023 | 224,000.00 |
| Sep 30, 2023 | 224,000.00 |
| Jun 30, 2023 | 224,000.00 |
| Mar 31, 2023 | 225,000.00 |